Events
News & Events
-
February 28, 2017
Considerations for Requiring Subjects to Respond to PRO Instruments Collected Electronically
This webinar provides an overview of specific considerations related to allowing subjects to opt out of responding to individual items when PRO data collection is electronic as well as the relevance to other types of electronic clinical outcome assessments. Presenters: Paul O’Donohoe, MS (CRF Health) and Sonya Eremenco, MA (C-Path) PDF version... -
January 31, 2017
Bring Your Own Device (BYOD)
This webinar provides an overview of scientific, logistical, and regulatory considerations when using a BYOD approach to collect patient-reported outcome data in clinical trials. Presenters: Jennifer Crager (YPrime) and Paul O’Donohoe, MS (CRF Health) PDF version... -
December 23, 2016
World Parkinson’s Congress 2016: Summary and Photos
In September, Critical Path for Parkinson’s (CPP) participated in the World Parkinson’s Congress in Portland, Oregon. This is a unique meeting that brings together people living with Parkinson’s disease (PD), their care partners, and leading researchers, to learn of current advances in PD research and therapies. This year was the best turnout to date, with...... -
October 27, 2016
Ensuring Equivalence of Electronic and Paper Administration of Patient-Reported Outcome Measures
This webinar provides an overview of scientific and regulatory considerations when migrating paper-based patient-reported outcome (PRO) measures to electronic modes of data collection. Presenters: Paul O’Donohoe, MS (CRF Health) and Willie Muehlhausen, DVM (ICON) PDF version... -
October 12, 2016
Coalition Against Major Diseases 2016 Annual Regulatory Science Workshop
October 12, 2016 College Park Marriott Hotel and Conference Center, Hyattsville, Maryland SPONSORED BY: Critical Path Institute MEETING MINUTES [PDF] (Presentations are linked in the agenda, below.) Overview and Objectives The Coalition Against Major Diseases (CAMD) is a public-private partnership aimed at developing creating Drug Development Tools that can be applied to increase......